Your shopping cart is currently empty

LCL521 dihydrochloride is a dual inhibitor of acid ceramidase (ACDase) and lysosomal acid sphingomyelinase (ASMase). By targeting these lysosomal enzymes, LCL521 dihydrochloride modulates sphingolipid metabolism, with potential applications in cancer and metabolic disorder research.

| Pack Size | Price | USA Warehouse | Global Warehouse | Quantity |
|---|---|---|---|---|
| 25 mg | $987 | 6-8 weeks | 6-8 weeks | |
| 50 mg | $1,360 | 6-8 weeks | 6-8 weeks | |
| 100 mg | $2,190 | 6-8 weeks | 6-8 weeks |
| Description | LCL521 dihydrochloride is a dual inhibitor of acid ceramidase (ACDase) and lysosomal acid sphingomyelinase (ASMase). By targeting these lysosomal enzymes, LCL521 dihydrochloride modulates sphingolipid metabolism, with potential applications in cancer and metabolic disorder research. |
| In vitro | LCL521 dihydrochloride is a potent cellular ACDase inhibitor at a concentration of 1 µM. At a higher concentration (10 µM), LCL521 dihydrochloride additionally exerts a reducing effect on the α-form of ACDase. Specifically, in MCF7 cells, LCL521 dihydrochloride (10 µM) induces a time-dependent decrease in the α-ACDase form, which is observable within 1 to 5 hours.[1] |
| Synonyms | LCL 521 dihydrochloride, 1,3DMG-B13 dihydrochloride |
| Molecular Weight | 665.69 |
| Formula | C31H54Cl2N4O7 |
| Cas No. | 1226759-47-2 |
| Smiles | CCCCCCCCCCCCCC(N[C@H](COC(CN(C)C)=O)[C@@H](C1=CC=C(C=C1)[N+]([O-])=O)OC(CN(C)C)=O)=O.Cl.Cl |
| Relative Density. | 1.31g/cm3 |
| Storage | store at low temperature | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice/Shipping at ambient temperature. | ||||||||||||||||||||||||||||||||||||||||
| Solubility Information | H2O: 20 mg/mL (30.04 mM), Sonication is recommended. DMSO: 80 mg/mL (120.18 mM), Sonication is recommended. | ||||||||||||||||||||||||||||||||||||||||
| In Vivo Formulation | 10% DMSO+40% PEG300+5% Tween 80+45% Saline: 3.3 mg/mL (4.96 mM), Sonication is recommended. Please add the solvents sequentially, clarifying the solution as much as possible before adding the next one. Dissolve by heating and/or sonication if necessary. Working solution is recommended to be prepared and used immediately. The formulation provided above is for reference purposes only. In vivo formulations may vary and should be modified based on specific experimental conditions. | ||||||||||||||||||||||||||||||||||||||||
Solution Preparation Table | |||||||||||||||||||||||||||||||||||||||||
H2O/DMSO
DMSO
| |||||||||||||||||||||||||||||||||||||||||
Dissolve 2 mg of the compound in 100 μL DMSO
to obtain a stock solution at a concentration of 20 mg/mL . If the required concentration exceeds the compound's known solubility, please contact us for technical support before proceeding.
1) Add 100 μL of the DMSO
stock solution to 400 μL PEG300
and mix thoroughly until the solution becomes clear.
2) Add 50 μL Tween 80 and mix well until fully clarified.
3) Add 450 μL Saline,PBS or ddH2O
and mix thoroughly until a homogeneous solution is obtained.
| Size | Quantity | Unit Price | Amount | Operation |
|---|

Copyright © 2015-2026 TargetMol Chemicals Inc. All Rights Reserved.